Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced it will present 11 scientific abstracts at the International Society of Physical and Rehabilitation Medicine ...

Background OnabotulinumtoxinA has demonstrated significant benefit in adult focal spasticity. This study reviews the injection patterns (i.e., muscle distribution, dosing) of onabotulinumtoxinA for ...

Spasticity causes chronic muscle tightness and stiffness that keep muscles contracted, reducing mobility and affecting both large movements like walking and fine motor skills like eating or writing.

Managing spasticity involves a comprehensive approach that combines medical treatments such as oral medications and Botox injections with daily self-care practices, including stretching, exercise, and ...

Animal or in vitro studies, studies performed in pediatric populations, and studies reporting treatment with BoNT products other than onabotulinumtoxinA were excluded. The full-text publications of ...